Overall, the effects on enhancer and gene activation by mutp53 and NFκB enhancer landscapes in response to chronic TNF-α signaling support our proposed model (Fig. 6b), which is consistent with an emerging regulatory network of mutp53 in orchestrating chronic inflammation-induced colon cancer. The gene discussed is NFKB1; the disease is colonic neoplasm.